226 related articles for article (PubMed ID: 11297259)
1. Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human T98G glioblastoma multiforme xenografts.
Teicher BA; Menon K; Alvarez E; Galbreath E; Shih C; Faul M
Clin Cancer Res; 2001 Mar; 7(3):634-40. PubMed ID: 11297259
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human HT-29 colon carcinoma and human CaKi1 renal cell carcinoma xenografts.
Teicher BA; Menon K; Alvarez E; Galbreath E; Shih C; Faul MM
Anticancer Res; 2001; 21(5):3175-84. PubMed ID: 11848470
[TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human breast cancer and ovarian cancer xenografts.
Teicher BA; Menon K; Alvarez E; Shih C; Faul MM
Invest New Drugs; 2002 Aug; 20(3):241-51. PubMed ID: 12201487
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic and antitumor effects of a protein kinase C beta inhibitor in human hepatocellular and gastric cancer xenografts.
Teicher BA; Menon K; Alvarez E; Liu P; Shih C; Faul MM
In Vivo; 2001; 15(3):185-93. PubMed ID: 11491013
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic effects of a protein kinase Cbeta-selective small molecule.
Teicher BA; Alvarez E; Menon K; Esterman MA; Considine E; Shih C; Faul MM
Cancer Chemother Pharmacol; 2002 Jan; 49(1):69-77. PubMed ID: 11855754
[TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in murine lewis lung carcinoma and human Calu-6 non-small-cell lung carcinoma xenografts.
Teicher BA; Menon K; Alvarez E; Galbreath E; Shih C; Faul MM
Cancer Chemother Pharmacol; 2001 Dec; 48(6):473-80. PubMed ID: 11800028
[TBL] [Abstract][Full Text] [Related]
7. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
[TBL] [Abstract][Full Text] [Related]
8. Effect of 1,19-bis(ethylamino)-5,10,15-triazanonadecane on human tumor xenografts.
Dolan ME; Fleig MJ; Feuerstein BG; Basu HS; Luk GD; Casero RA; Marton LJ
Cancer Res; 1994 Sep; 54(17):4698-702. PubMed ID: 8062267
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo inhibition of glioblastoma and neuroblastoma with MDL101731, a novel ribonucleoside diphosphate reductase inhibitor.
Piepmeier JM; Rabidou N; Schold SC; Bitonti AJ; Prakash NJ; Bush TL
Cancer Res; 1996 Jan; 56(2):359-61. PubMed ID: 8542592
[TBL] [Abstract][Full Text] [Related]
10. Activity of fotemustine in medulloblastoma and malignant glioma xenografts in relation to O6-alkylguanine-DNA alkyltransferase and alkylpurine-DNA N-glycosylase activity.
Vassal G; Boland I; Terrier-Lacombe MJ; Watson AJ; Margison GP; VĂ©nuat AM; Morizet J; Parker F; Lacroix C; Lellouch-Tubiana A; Pierre-Kahn A; Poullain MG; Gouyette A
Clin Cancer Res; 1998 Feb; 4(2):463-8. PubMed ID: 9516937
[TBL] [Abstract][Full Text] [Related]
11. Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class.
Kilic T; Alberta JA; Zdunek PR; Acar M; Iannarelli P; O'Reilly T; Buchdunger E; Black PM; Stiles CD
Cancer Res; 2000 Sep; 60(18):5143-50. PubMed ID: 11016641
[TBL] [Abstract][Full Text] [Related]
12. LY317615 decreases plasma VEGF levels in human tumor xenograft-bearing mice.
Keyes KA; Mann L; Sherman M; Galbreath E; Schirtzinger L; Ballard D; Chen YF; Iversen P; Teicher BA
Cancer Chemother Pharmacol; 2004 Feb; 53(2):133-40. PubMed ID: 14593497
[TBL] [Abstract][Full Text] [Related]
13. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
14. Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxynucleotide.
Yazaki T; Ahmad S; Chahlavi A; Zylber-Katz E; Dean NM; Rabkin SD; Martuza RL; Glazer RI
Mol Pharmacol; 1996 Aug; 50(2):236-42. PubMed ID: 8700129
[TBL] [Abstract][Full Text] [Related]
15. Combined modality treatment using radiation and/or chemotherapy in an athymic nude mouse-human medulloblastoma and glioblastoma xenograft model.
Slagel DE; Feola J; Houchens DP; Ovejera AA
Cancer Res; 1982 Mar; 42(3):812-6. PubMed ID: 7059979
[TBL] [Abstract][Full Text] [Related]
16. In vivo/ex vivo and in situ assays used in cancer research: a brief review.
Teicher BA
Toxicol Pathol; 2009 Jan; 37(1):114-22. PubMed ID: 19098118
[TBL] [Abstract][Full Text] [Related]
17. Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme.
Phuong LK; Allen C; Peng KW; Giannini C; Greiner S; TenEyck CJ; Mishra PK; Macura SI; Russell SJ; Galanis EC
Cancer Res; 2003 May; 63(10):2462-9. PubMed ID: 12750267
[TBL] [Abstract][Full Text] [Related]
18. Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and imatinib (Gleevec).
Oertel S; Krempien R; Lindel K; Zabel A; Milker-Zabel S; Bischof M; Lipson KE; Peschke P; Debus J; Abdollahi A; Huber PE
Strahlenther Onkol; 2006 Jul; 182(7):400-7. PubMed ID: 16826359
[TBL] [Abstract][Full Text] [Related]
19. Effects of SU101 in combination with cytotoxic agents on the growth of subcutaneous tumor xenografts.
Strawn LM; Kabbinavar F; Schwartz DP; Mann E; Shawver LK; Slamon DJ; Cherrington JM
Clin Cancer Res; 2000 Jul; 6(7):2931-40. PubMed ID: 10914743
[TBL] [Abstract][Full Text] [Related]
20. Verotoxin induces apoptosis and the complete, rapid, long-term elimination of human astrocytoma xenografts in nude mice.
Arab S; Rutka J; Lingwood C
Oncol Res; 1999; 11(1):33-9. PubMed ID: 10451029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]